Category: Cardiovascular disease

  • Introduction Apolipoprotein B (ApoB) has emerging evidence as the marker to predict the risk of cardiovascular disease for primary prevention. Systematic reviews and meta-analyses released in the last few years demonstrate it is a valuable tool we can use in Australian General Practice. At this stage, the General Practice in Australia has not yet adapted…

  • Introduction This changed when I was undertaking my training in 2023 where new recommendations were made where the Framingham equation was replaced with the newer AusCVDRisk Calculator for primary prevention. The new calculator can be found at https://www.cvdcheck.org.au/ There is some nuance to risk assessment. The pathway can be very algorithmic in nature. What I…